Results 11 to 20 of about 28,020 (301)
Value of Neurofilament Light Chain as a Biomarker in Peripheral Neuropathy [PDF]
Zhongguo quanke yixue, 2022 Neurofilament light chain (NfL) has been identified as a biomarker of axonal injury in a variety of central nervous system diseases. The value of NfL as a biomarker in peripheral neuropathy has gained increasing attention.
SUN Xiaoling, HUANG Kaiwei, WAN Xinbei, WU Ying, LI Zhijun
doaj +1 more source
Seminars in Neurology, 2015 Diabetes mellitus is a common condition and diabetics are prone to develop a spectrum of neuropathic complications ranging from symmetric and diffuse to asymmetric and focal neuropathies that may be associated with significant morbidity. Diabetic sensorimotor polyneuropathy is the most common of these complications, occurring in patients with type 1 ...
Aaron, Izenberg +2 more
openaire +2 more sources
Diagnosing Diabetic Neuropathy: Something Old, Something New [PDF]
Diabetes & Metabolism Journal, 2018 There are potentially many ways of assessing diabetic peripheral neuropathy (DPN). However, they do not fulfill U.S. Food and Drug Administration (FDA) requirements in relation to their capacity to assess therapeutic benefit in clinical trials of DPN ...
Ioannis N. Petropoulos +5 more
doaj +1 more source
Biomedicines, 2022 A large number of peripheral neuropathies, among which are traumatic and diabetic peripheral neuropathies, result from the degeneration of the myelin sheath, a process called demyelination.
Nicolas Tricaud +4 more
doaj +1 more source
Interdisciplinary Neurosurgery, 2021 Background: This study attempts to evaluate the utility of nerve biopsy in complementing or redirecting clinical diagnosis. Several factors determine the diagnostic utility of nerve biopsy, the most important being pre-biopsy diagnosis, with higher ...
Jitesh Goel +4 more
doaj +1 more source
Corneal confocal microscopy differentiates inflammatory from diabetic neuropathy
Journal of Neuroinflammation, 2021 Background Immune-mediated neuropathies, such as chronic inflammatory demyelinating polyneuropathy (CIDP) are treatable neuropathies. Among individuals with diabetic neuropathy, it remains a challenge to identify those individuals who develop CIDP ...
Michael Fleischer +9 more
doaj +1 more source
Acute diabetic neuropathy following improved glycaemic control: a case series and review
Endocrinology, Diabetes & Metabolism Case Reports, 2020 We present three cases of acute diabetic neuropathy and highlight a potentially underappreciated link between tightening of glycaemic control and acute neuropathies in patients with diabetes.
N Siddique +5 more
doaj +1 more source
An Insight into Potential Pharmacotherapeutic Agents for Painful Diabetic Neuropathy
Journal of Diabetes Research, 2022 Diabetes is the 4th most common disease affecting the world’s population. It is accompanied by many complications that deteriorate the quality of life. Painful diabetic neuropathy (PDN) is one of the debilitating consequences of diabetes that effects one-
Zunaira Qureshi +2 more
doaj +1 more source
Anais da Academia Brasileira de Ciências, 2023 We report on a systematic review of the efficacy of turmeric derivatives for the in vivo treatment of peripheral neuropathies. Our review protocol followed the PRISMA Statement. The Medline (PubMed), Web of Science, Scopus, and Scielo databases were used.
RAFAEL S. SILVEIRA +4 more
doaj +1 more source
The pathophysiology of diabetic foot: a narrative review [PDF]
Journal of Yeungnam Medical Science, 2023 An aging population and changes in dietary habits have increased the incidence of diabetes, resulting in complications such as diabetic foot ulcers (DFUs). DFUs can lead to serious disabilities, substantial reductions in patient quality of life, and high
Jiyoun Kim
doaj +1 more source